| 产品描述: | CLK1-IN-2 is metabolically stable Clk1 inhibitor. CLK1-IN-2 has selectivity for Clk1 with an IC50 value of 1.7 nM. CLK1-IN-2 can be used for the research of tumour, Duchenne's muscular dystrophy and viral infections such as HIV-1 and influenza. |
| 体内研究: |
CLK1-IN-2 (Compound 27a) has selectivity for Clk1 with an IC50 value of 1.7 nM. CLK1-IN-2 shows long metabolic half-lives of 6.4 h. CLK1-IN-2exhibits a GI50 of 3.4 μM in T24 cancer cells. CLK1-IN-2 shows a cellular Ki valiue of 0.051 μM in NanoBRET cellular Clk1 engagement assay. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.723 ml |
13.615 ml |
27.229 ml |
| 5 mM |
0.545 ml |
2.723 ml |
5.446 ml |
| 10 mM |
0.272 ml |
1.361 ml |
2.723 ml |
| 50 mM |
0.054 ml |
0.272 ml |
0.545 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |